In our latest Psychedelic Patent Analysis, we take a deep dive into recent patent-related developments at two companies that are both pursuing 5-MeO-DMT for treatment-resistant depression (TRD): GH Research and Beckley Psytech. This case study raises questions not only about how these two specific companies’ IP might shake out, but also about how other types of exclusivity—such as data and market…
Two type 1 diabetes patients are insulin-free after Eledon’s immunosuppressant and an islet transplant
Eledon Pharmaceuticals’ experimental immunosuppressant helped two patients with type 1 diabetes go insulin-free following an islet cell transplant, the company announced Tuesday. The company’s stock